STAT

Dear Atul Gawande: As you go on your listening tour, don’t forget about mental health

Dear @Atul_Gawande, as you go on your listening tour for your @Amazon health care venture, listen to me: Don't forget about mental health. You have a chance to make a…

It’s too early to know Dr. Atul Gawande’s priorities in his new role as CEO of the yet-to-be-named health care venture of Amazon, Berkshire Hathaway, and JPMorgan. My colleagues at STAT report that before anything else, he’ll embark on a listening tour.

So, Dr. Gawande, I’d like you to listen to me for a moment: Whatever you create, however you disrupt, you need to treat the mental health needs of the people you serve with the same consideration and care as their physical health needs.

On a recent Sunday, I

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Cigna Biosimilar Plans, A Vertex Deal In South Africa, And More
Cigna plans to make copies of AbbVie's Humira arthritis drug available with no out-of-pocket payment to eligible patients in the U.S.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About CVS And Humira Biosimilars, Schumer’s Broken Insulin Promise, And More
New prescriptions for biosimilar versions of Humira, one of the best-selling drugs in the U.S., surged to 36% from just 5% during the first week of April.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Biocon Eyeing Weight Loss Drugs, Sanofi Layoffs, And More
Biocon is pivoting to weight loss drugs as patents for the blockbuster medicines start to expire, unleashing a coming wave of generics.

Related Books & Audiobooks